These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2180659)

  • 1. Feasibility of adjustment of insulin dose by insulin-requiring type II diabetic patients.
    Floyd JC; Funnell MM; Kazi I; Templeton C
    Diabetes Care; 1990 Apr; 13(4):386-92. PubMed ID: 2180659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial.
    Henry RR; Gumbiner B; Ditzler T; Wallace P; Lyon R; Glauber HS
    Diabetes Care; 1993 Jan; 16(1):21-31. PubMed ID: 8422777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
    Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
    Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
    Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving glycemic control with insulin detemir using the 303 Algorithm in insulin naïve patients with type 2 diabetes: a subgroup analysis of the US PREDICTIVE 303 study.
    Selam JL; Koenen C; Weng W; Meneghini L
    Curr Med Res Opin; 2008 Jan; 24(1):11-20. PubMed ID: 18021495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer-assisted insulin dosage adjustment.
    Schiffrin A; Mihic M; Leibel BS; Albisser AM
    Diabetes Care; 1985; 8(6):545-52. PubMed ID: 3908025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing.
    Allen BT; DeLong ER; Feussner JR
    Diabetes Care; 1990 Oct; 13(10):1044-50. PubMed ID: 2170088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taking a Closer Look--Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients with Type 2 Diabetes Mellitus Under Basal-Bolus Insulin Therapy.
    Schaupp L; Donsa K; Neubauer KM; Mader JK; Aberer F; Höll B; Spat S; Augustin T; Beck P; Pieber TR; Plank J
    Diabetes Technol Ther; 2015 Sep; 17(9):611-8. PubMed ID: 25927357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS.
    Ji L; Su Q; Feng B; Shan Z; Hu R; Xing X; Xue Y; Yang T; Hua Y
    J Diabetes; 2017 May; 9(5):495-501. PubMed ID: 27249791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.
    Hollander P; Cooper J; Bregnhøj J; Pedersen CB
    Clin Ther; 2008 Nov; 30(11):1976-87. PubMed ID: 19108786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proportion of daily capillary blood glucose readings required in the target range for target glycaemic control: shift of focus from target range to proportion in range.
    Sivasubramaniyam S; Amiel SA; Choudhary P
    Diabet Med; 2017 Oct; 34(10):1456-1460. PubMed ID: 28763121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of patients with type 2 diabetes by pharmacists in primary care clinics.
    Coast-Senior EA; Kroner BA; Kelley CL; Trilli LE
    Ann Pharmacother; 1998 Jun; 32(6):636-41. PubMed ID: 9640480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections.
    Schiffrin A; Belmonte M
    Diabetes Care; 1982; 5(5):479-84. PubMed ID: 6765224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HbA1c levels are better predicted by prebreakfast than postbreakfast blood glucose self-analyses in type 2 diabetes. Influence of duration of diabetes and mode of treatment.
    Relimpio F; Guerrero R; Martínez-Brocca MA
    Acta Diabetol; 2007 Jun; 44(2):55-9. PubMed ID: 17530467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective trial of U500 insulin delivered by Omnipod in patients with type 2 diabetes mellitus and severe insulin resistance.
    Lane WS; Weinrib SL; Rappaport JM; Przestrzelski T
    Endocr Pract; 2010; 16(5):778-84. PubMed ID: 20350913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal-bolus therapy with insulin detemir using the 303 algorithm in the US PREDICTIVE 303 trial.
    Selam JL; Meneghini LF
    Adv Ther; 2009 Feb; 26(2):194-207. PubMed ID: 19259629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and Safety of Physician-Led Versus Patient-Led Titration of Insulin Glargine in Indian Patients with Type 2 Diabetes Mellitus: A Subanalysis of the Asian Treat to Target Lantus Study (ATLAS).
    Misra A; Patel M; Agarwal P; Lodha S; Tandon N; Magdum M; Yajnik C; Ghosh R; Walekar A
    Diabetes Technol Ther; 2019 Nov; 21(11):656-664. PubMed ID: 31335198
    [No Abstract]   [Full Text] [Related]  

  • 20. Can a tool that automates insulin titration be a key to diabetes management?
    Bergenstal RM; Bashan E; McShane M; Johnson M; Hodish I
    Diabetes Technol Ther; 2012 Aug; 14(8):675-82. PubMed ID: 22568777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.